Clinical Trials in Salt Lake City

Showing 5021-5040 of 16,694 trials

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

NCT04817644

Participants in the study, will receive the study drug once daily for 10 days in tablet form for oral (by mouth) intake. On day 1 to 5 the tablet will contain 3 mg semaglutide, and on day 6-10 the tablet will contain 7 mg semaglutide.

Diabetes Mellitus, Type 2

Novo Nordisk A/S14 participantsStarted Sep 2021

San Antonio, Texas, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

NCT02187003

This is a clinical study evaluating the efficacy and safety of rivipansel (GMI-1070) in treating subjects with sickle cell disease (SCD) who are 6 years of age or older experiencing a pain crisis necessitating hospitalization.

Anemia, Sickle Cell

Biossil Inc.345 participantsStarted Jun 2015

Mobile, Alabama, United States • Little Rock, Arkansas, United States • Little Rock, Arkansas, United States +139 more locations

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Find Trials by Condition in Salt Lake City

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

Physiology of Unloading VA ECMO Trial

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Post-Market Registry in Europe and US for the Use of VascuCelTM

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Alcohol Research Consortium in HIV-Intervention Research Arm